| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062066A2 For higher basidiomycetes mushrooms grown (as one cell biomass) in submerged culture |
| 08/30/2001 | WO2001053474A8 Flavobacterium heparinum expression system |
| 08/30/2001 | WO2001026458A3 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 08/30/2001 | WO2001025421A3 Materials and method for detecting interaction of cftr polypeptides |
| 08/30/2001 | WO2001012833A3 Process for the biological production of 1,3-propanediol |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001011017A3 Materials and methods for the efficient production of pasteuria |
| 08/30/2001 | WO2001009350A3 Genetically engineered bleb vaccine |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2000073794A3 Method for separating cells using immunorosettes |
| 08/30/2001 | WO2000071729A3 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | US20010018773 Production of cotton fiber with improved fiber characteristics |
| 08/30/2001 | US20010018509 Growth differeniation factor-3 |
| 08/30/2001 | US20010018214 Culturing retrovirally infected eukaryotic cells in aseptic, low oxygen conditions; bacteria produced contain eukaryotic and viral genes |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | CA2402398A1 Process for producing avermectin derivative |
| 08/30/2001 | CA2401219A1 Vertebrate globin |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127495A1 Method for classifying specific tissue of oilseeds or cereals and finely milled powders |
| 08/29/2001 | EP1127164A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION |
| 08/29/2001 | EP1127160A2 Parallel methods for genomic analysis |
| 08/29/2001 | EP1127157A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 08/29/2001 | EP1127152A1 A method of recombination and agents useful for same |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127141A1 Method for expressing recombinant proteins using the effect of stress and stress response mechanisms in the presence of compatible solutes |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127136A1 Delivery of superoxide dismutase to neuronal cells |
| 08/29/2001 | EP1127135A2 High fidelity thermostable ligase and uses thereof |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127116A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 08/29/2001 | EP1127114A1 Method of isolating plasmid dna |
| 08/29/2001 | EP1127103A1 Recombinant extracellular chitinases and uses thereof |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127066A1 Modified proteins |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP0792290B1 Acylated insulin |
| 08/29/2001 | EP0547065B1 Melanin production by transformed microorganisms |
| 08/29/2001 | CN1310761A Enzyme |
| 08/29/2001 | CN1310759A Therapeutic and diagnostic domain 1 & beta 2GP1 polypeptides and methods of using same |
| 08/29/2001 | CN1310757A Novel mannanases |
| 08/29/2001 | CN1310756A Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
| 08/29/2001 | CN1310755A Transferring materials into cells using porous silicon |
| 08/29/2001 | CN1310234A Alph-ketoglutaric acid dehydrase gene |
| 08/29/2001 | CN1310233A Mutant iLvH gene and process for producing L-valine |
| 08/29/2001 | CN1310232A Process for producing protease |
| 08/29/2001 | CN1310230A Bacillus thuringiensis strain fermentation process and pesticide application |
| 08/29/2001 | CN1310229A PR5 bacteria preparation to inhibit phytophthora disease |
| 08/29/2001 | CN1310150A CO2 gas fertilizer and its production process |
| 08/29/2001 | CN1310016A Acid resistant enteric coated capsule of active binding bifidobacterium strain and its preparation |
| 08/29/2001 | CN1309885A Industrial culture of Gastrodia elata |
| 08/28/2001 | USRE37343 Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences |
| 08/28/2001 | US6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 08/28/2001 | US6281016 Broad-spectrum insect resistant transgenic plants |
| 08/28/2001 | US6281011 Random fragmentation of dna; transferring to expression vector; screening or selecting suppression |
| 08/28/2001 | US6281000 Dna fragment cloning into genome of recombinant adenoviral plasmid vector; human gene therapy |
| 08/28/2001 | US6280998 Genetic engineering; nucleotide vector |
| 08/28/2001 | US6280997 Isolated nucleic acid molecule which codes for a 32 KDA protein having 11-CIS retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor |
| 08/28/2001 | US6280996 Method of using oxygen to eliminate carbon dioxide poisoning in aerobic fermentation |
| 08/28/2001 | US6280984 DNA constructs and methods of producing cellulytic enzymes |
| 08/28/2001 | US6280975 Adjusted interleukin polypeptide for use in the treatment of myelomas, tumors, osteoporosis and autoimmune diseases |
| 08/28/2001 | US6280972 Generating modulator of enzymatic activity; culture cells transformed with expression vector coding enzymatic modulator, recover enzymatic modulator |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280969 Growth arrest homeobox gene |
| 08/28/2001 | US6280963 Essential fungal genes and their use |
| 08/28/2001 | US6280926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same |
| 08/28/2001 | US6280738 Non-IgA Fc binding forms of the group B streptococcal β antigens |
| 08/28/2001 | US6280735 Polypeptides of riboflavin specific deaminase family |
| 08/28/2001 | US6280733 Purified polypeptide comprising specified amino acid sequence, wherein said polypeptide binds to microtubules |
| 08/28/2001 | US6280722 Antifungal Bacillus thuringiensis strains |
| 08/28/2001 | US6280721 Production of Bacillus thuringiensis integrants |
| 08/28/2001 | US6280720 Integrant of bacillus thuringiensis or spore thereof which produces homologous or heterologous crystal delta-endotoxin, having greater pesticidal activity than corresponding parental strain by producing larger quantity of endotoxin |
| 08/28/2001 | US6280719 Antifungal biocontrol agents, a process for preparing and treating the same |